6:01am PDT - March 23rd, 2022

EAA171/OPTIMUM, led by @myelomaMD of @mayoclinic, aims to optimize prolonged treatment in #myeloma using MRD assessment. Learn more about this myeloma trial for #MyelomaAwarenessMonth here: https://t.co/JqYmEXuDpt #mmsm cc: @mtmdphd @VincentRK @NorthTxMSG https://t.co/Z1lfamXtdS

0 retweets   0 likes  - ECOG-ACRIN Cancer Research Group (@eaonc)